Essais liés3clinical trials
VilleChongqinglocalisation
PaysChinalocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT07835152

Ouvrir le site du centre

Essais cliniques associés

3
MoléculeIndication / populationPhaseNCTTitreStatut
BR005-036C Migraine Phase 3 NCT07835152 Long-term Safety of BR005-036C Tablets in the Acute Treatment of Migraine in Adults NOT_YET_RECRUITING
Rimegepant Migraine Phase 3 NCT05810038 A Study to Learn About the Safety and Effects of Rimegepant to Prevent Migraine in Chinese Subjects. COMPLETED
BR005-036C Migraine Phase 2/3 NCT07792681 Efficacy and Safety of BR005-036C Tablets for the Acute Treatment of Migraine in Adults RECRUITING